Hepatoprotectors. Captured S. et al.

This publication analyzes and systematizes information on the clinical use of drugs for which hepatotropic effects are the main, predominant or independent clinical value. In our opinion, this is relevant, since the final judgment on the boundaries of the use, efficiency and safety of hepatoprotectors has not yet been formed, due to the extremely small number of clinical studies of this group of drugs that meet modern principles of evidence -based medicine.

in The book provides data on the composition of hepatoprotectors, action mechanisms, pharmacokinetics, the features of clinical use, and clinical studies with a particular pathology, side effects. Information about new drugs is included, the rational choice of drugs and their optimal doses, the principles of use are considered, which allows you to use this leadership not only in medical practice, but also in the study of clinical pharmacology.

The publication is intended for therapists, gastroenterologists, scientists and students of senior courses of medical universities.